Global Blood Therapeutics, Inc.
GBTDelisted Oct 5, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001629137
Global Blood Therapeutics, Inc. was delisted on Oct 5, 2022; its insiders filed their last Form 4 on Oct 6, 2022; 247 institutions reported holding it in 13F filings for Q3 2022, worth $4.67B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Global Blood Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 1 | 1 | 0 |
| Shares | 1 | 1 | 0 (0.0%) |
| Value | $68 | $68 | $0 (0.0%) |
New holders (0)
Institutions that held Global Blood Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
None.
Sold out (0)
Institutions that held Global Blood Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
None.